Mustang Bio Inc.
MBIO | NASDAQ
$0.55
+$0.01 (+1.91%)
At close: Sep 21, 2026, 4:00 PM ET
$0.55
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 41K | n/a | 2.23M | 3.03M | 2.31M | 1.79M |
Gross Profit | -41K | n/a | -2.23M | -3.03M | -2.31M | -1.79M |
Operating Income | -2.43M | -16.25M | -50.73M | -76.16M | -66.72M | -56.81M |
Interest Income | 511K | 184K | 850K | 689K | 368K | 708K |
Pretax Income | -1.92M | -15.75M | -51.6M | -77.53M | -66.37M | -60.02M |
Net Income | -1.92M | -15.75M | -51.6M | -77.53M | -66.37M | -60.02M |
Selling & General & Admin | 3.95M | 4.14M | 9.32M | 12.21M | 11.02M | 9.51M |
Research & Development | 1.52M | 8.42M | 39.18M | 63.95M | 53.54M | 45.62M |
Other Expenses | -3.07M | 3.69M | n/a | -3.03M | -139K | -108K |
Operating Expenses | 2.39M | 16.25M | 48.5M | 73.13M | 64.42M | 55.02M |
Interest Expense | n/a | -5K | 1.31M | 3.36M | 15K | 3.92M |
Selling & Marketing Expenses | n/a | n/a | -365K | n/a | n/a | n/a |
Cost & Expenses | 2.43M | 16.25M | 50.73M | 76.16M | 66.72M | 56.81M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 4.91M | 6.13M | 8.6M | 6.9M | 5.86M | 3.51M |
Shares Outstanding (Diluted) | 4.91M | 6.13M | 8.6M | 6.9M | 5.86M | 3.51M |
EPS (Basic) | -0.39 | -2.57 | -6 | -11.25 | -11.40 | -17.10 |
EPS (Diluted) | -0.39 | -2.57 | -6 | -11.25 | -11.40 | -17.10 |
EBITDA | -1.88M | -14.92M | -48.06M | -71.14M | -64.05M | -54.31M |
EBIT | -1.92M | -15.75M | -50.29M | -74.17M | -66.36M | -56.1M |
Depreciation & Amortization | 41K | 823K | 2.23M | 3.03M | 2.31M | 1.79M |
Add to Watchlist
Select watchlists to add or remove MBIO